Clinical Trials Search Results

This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell carcinoma that has spread to other parts of the body.

This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell carcinoma that has spread to other parts of the body.

This is a Phase III, randomized, parallel-arm, placebo controlled, double blind, multicenter study assessing the efficacy and safety of durvalumab versus placebo following SoC chemotherapy in patients with completely resected stage II-III NSCLC who are MRD+ post surgery

3 chemos: bendamustine, rituximab, high dose cytarabine & acalabrutinib & studies how well they work in treating patients w/ newly diagnosed mantle cell lymphoma

Ph 3, Rand,Placebo-Controlled,Double-Blind,Multicenter Trial ofSelinexor in Maint.Therapy After Systemic Therapy for Ptsw/p53 Wild-Type, Adv or Recurrent Endometrial Carcinoma